The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples